Athena Global Investors’s Bristol-Myers Squibb BMY Stock Holding History

Athena Global Investors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$640K	Buy	11,772 +3,047	+35%	+$167K	1.92%	22
2016 Q4	$510K	Hold	8,725	–	–	1.24%	26
2016 Q3	$470K	Hold	8,725	–	–	1.22%	29
2016 Q2	$642K	Sell	8,725 -3,705	-30%	-$262K	0.99%	29
2016 Q1	$794K	Hold	12,430	–	–	0.82%	28
2015 Q4	$855K	Sell	12,430 -1,500	-11%	-$99.1K	0.82%	29
2015 Q3	$825K	Sell	13,930 -10,070	-42%	-$639K	0.84%	29
2015 Q2	$1.55M	Hold	24,000	–	–	1.4%	26
2015 Q1	$1.55M	Hold	24,000	–	–	1.1%	27
2014 Q4	$1.42M	Hold	24,000	–	–	0.97%	26
2014 Q3	$1.23M	Hold	24,000	–	–	0.56%	27
2014 Q2	$1.16M	Hold	24,000	–	–	0.52%	27
2014 Q1	$1.25M	Buy	+24,000	New	+$1.28M	0.75%	25

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Athena Global Investors's BMY Position: Q1 2017 in Review

Athena Global Investors increased its Bristol-Myers Squibb (BMY) stake by 35% in Q1 2017, buying an estimated $167K and bringing the position to 11,772 shares worth $640K. The position accounts for 1.92% of the portfolio, ranked #22.

Athena Global Investors first reported a position in BMY in Q1 2014 and has held it in 13 quarters since. The position peaked at $1.55M in Q2 2015. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

Athena Global Investors held 11,772 shares of Bristol-Myers Squibb worth $640K as of Q1 2017.
Athena Global Investors bought 3,047 Bristol-Myers Squibb shares in Q1 2017, an estimated $167K.
Bristol-Myers Squibb made up 1.92% of Athena Global Investors's portfolio in Q1 2017, its #22 holding.
Athena Global Investors first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 13 quarters since.
Athena Global Investors's Bristol-Myers Squibb position peaked at $1.55M in Q2 2015.
1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Athena Global Investors's 13F filing for Q1 2017, filed 16 May 2017.